Looking Beyond Overall Survival: FDA-AACR Workshop Explored Novel Oncology Endpoints
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...